23 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ALNY

Alnylam Pharmaceuticals
US$248.79-6.0%52.7%US$30.2bUS$301.21PS15.3xE70.7%n/a

SRPT

Sarepta Therapeutics
US$110.86-1.4%32.3%US$10.2bUS$189.86PE86.9xE42.6%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

NBIX

Neurocrine Biosciences
US$123.29-1.8%11.1%US$12.1bUS$163.46PE32.3xE29.6%n/a

KRTX

Karuna Therapeutics
US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a

LLY

Eli Lilly
US$753.41-7.2%26.6%US$657.1bUS$992.18PE81.1xE29.5%0.7%

ABBV

AbbVie
US$167.76-1.5%21.2%US$294.4bUS$204.74PE58.3xE28.1%3.9%

INCY

Incyte
US$71.05-11.7%33.1%US$13.6bUS$78.05PE421.4xE46.3%n/a

BMY

Bristol-Myers Squibb
US$57.88-0.9%17.1%US$118.1bUS$59.37PS2.5xE48.6%4.1%

BGNE

BeiGene
US$194.26-0.6%6.3%US$19.9bUS$277.61PS6.4xE73.2%n/a

TEVA

Teva Pharmaceutical Industries
US$17.030.5%80.0%US$19.0bUS$22.36PS1.2xE65.8%0%

VRTX

Vertex Pharmaceuticals
US$451.23-8.8%27.7%US$115.4bUS$513.87PS10.9xE47.4%n/a

GILD

Gilead Sciences
US$88.63-4.3%17.1%US$109.2bUS$96.92PE875.7xE40.9%3.5%

NTRA

Natera
US$167.884.3%207.2%US$21.4bUS$164.40PS14.5xE69.9%n/a

AVTR

Avantor
US$20.14-6.7%0.2%US$13.4bUS$27.31PE44.3xE36.4%n/a

VTRS

Viatris
US$13.131.0%40.1%US$15.6bUS$13.08PS1xE53.5%3.7%

ILMN

Illumina
US$131.68-9.9%34.7%US$21.4bUS$164.60PS4.8xE70.4%2.4%

HZNP

Horizon Therapeutics
US$116.300.06%82.8%US$26.6bUS$116.50PE60.8xE16.4%n/a

MRK

Merck
US$97.44-1.1%-4.2%US$244.2bUS$131.08PE20.3xE15.6%3.2%

TECH

Bio-Techne
US$68.72-9.5%8.1%US$10.5bUS$85.25PE72.5xE21.2%0.5%

CTLT

Catalent
US$59.00-0.3%49.0%US$10.7bUS$63.43PS2.4xE74.5%n/a

BMRN

BioMarin Pharmaceutical
US$62.56-6.2%-29.2%US$11.8bUS$98.39PE37xE27.3%n/a

AMGN

Amgen
US$287.87-4.5%8.8%US$150.5bUS$334.06PE36.6xE19.1%3.1%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.